Recent SEC filings detail the company’s financial results, capital raises, and regulatory approvals related to its Medicare Advantage plan operations. No recent news headlines are available.

• The company reported a net loss of $7.8 million for fiscal year 2025 and a net loss of $2 million for the first nine months of 2025, primarily due to startup investments prior to revenue generation [S1][S2].
• Liquidity as of December 31, 2025, included $3.76 million in cash and equivalents, with a current ratio of 3.35 and cash ratio of 2.8, indicating sufficient short-term liquidity [S1].
• Elite Health Plan executed a contract with CMS as a Medicare Advantage organization and began onboarding members in October 2025, with services starting January 1, 2026 [S14].
• The company raised approximately $5.8 million in a private placement in early 2025 and over $3 million by September 30, 2025, to fund operations and business development [S2].
• Management disclosed substantial doubt about the company’s ability to continue as a going concern as of September 30, 2025, but believes its capital raise and expense management plans alleviate this doubt for at least twelve months [S2].

The company’s conditional approval to operate a Medicare Advantage plan and its ongoing capital raises provide a foundation for establishing a managed care organization targeting seniors in California. Successful onboarding of members and expansion into additional counties or states could build scale and operational experience. The company’s ability to manage expenses and secure additional capital could support growth and eventual revenue generation in a specialized healthcare segment with regulatory barriers to entry.

Elite Health Systems Inc. faces significant risks including the uncertainty of successfully implementing its Medicare Advantage plan strategy, maintaining necessary licenses and contracts, and acquiring sufficient members to generate revenue. The company has no current revenue and reports substantial net losses, relying heavily on equity financing. Lack of access to credit lines and ongoing capital needs raise concerns about liquidity and going concern status. Failure to raise capital on favorable terms or manage costs could impair operations and business viability.

Elite Health Systems Inc. operates in the highly regulated Medicare Advantage market, which requires obtaining and maintaining licenses and contracts with the Centers for Medicare and Medicaid Services (CMS). The company’s conditional approval and contract with CMS to operate as a Medicare Advantage plan provide a regulatory barrier to entry for competitors. However, the company is in an early stage with no revenue and faces significant execution risks. Its moat is primarily regulatory and contractual, dependent on maintaining CMS contracts and successfully scaling enrollment and operations in a competitive healthcare market.

• Execution Risk in Medicare Advantage Plan Development: Uncertainties exist regarding the company’s ability to successfully implement its strategy of developing and operating a Medicare Advantage plan through its subsidiary Elite Health Plan.
• Regulatory and Licensing Risk: Maintaining Medicare Advantage licenses and contracts with CMS is critical; failure to maintain these could significantly impair business operations.
• Capital Raising and Liquidity Risk: The company depends on raising capital through private placements and currently lacks access to credit lines, raising substantial doubt about its ability to continue as a going concern.
• Operational and Integration Risk: The company faces challenges in managing startup costs, integrating acquisitions such as Physician Support Systems, and controlling expenses to align with available cash resources.

• Elite Health Systems Inc. operates through its wholly owned subsidiary Elite Health Plan, which is a managed care organization that will operate a Medicare Advantage plan for seniors.
• Elite Health Plan has received conditional state and federal approval to operate as a Medicare Advantage plan and is onboarding members to begin providing services starting January 1, 2026.
• The company has no revenue as of the latest filings and incurs significant expenses related to startup and operational costs for the Medicare Advantage plan.
• The company reported a net loss of $7,804,000 for the fiscal year ended December 31, 2025, and a net loss of $2,026,000 for the nine months ended September 30, 2025.
• Basic earnings per share was -$0.35 for the fiscal year ended December 31, 2025, and diluted EPS was -$0.03 for the quarter ended March 31, 2024.
• Liquidity as of December 31, 2025, includes cash and equivalents of approximately $3.76 million, current assets of $4.48 million, and current liabilities of $1.34 million, resulting in a current ratio of 3.35 and a cash ratio of 2.8.
• The company has raised capital through private placements of common stock, including approximately $5.8 million in early 2025 and over $3 million raised by September 30, 2025, to fund operations and business development.
• The company’s business plan focuses on establishing and operating managed health care plans, primarily Medicare Advantage plans in California counties including San Bernardino, Los Angeles, and Riverside, with potential expansion to other states such as Nevada.
• The company does not currently have access to capital through lines of credit or other readily available sources, raising substantial doubt about its ability to continue as a going concern as of September 30, 2025.
• Management believes it can manage expenses to available cash resources and raise additional capital to support ongoing operations and alleviate going concern doubts for at least the next twelve months.
• Risk factors disclosed include uncertainties in successfully implementing the Medicare Advantage plan strategy, maintaining licenses, acquiring and expanding consumer enrollment, integrating acquisitions, raising capital on favorable terms, and managing liquidity and growth.